Cardiovascular Evaluation of Patients With High Cholesterol and Normal Volunteers
|ClinicalTrials.gov Identifier: NCT00001204|
Recruitment Status : Completed
First Posted : November 4, 1999
Last Update Posted : March 29, 2018
Homozygous familial hypercholesterolemia is a rare inherited disease of metabolism. It occurs in less than 1 in 1 million people within the United States. Patients with the disease are typically children and young adults who develop heart disease early in life. Children less than age 5 years with this disease have suffered heart attacks and death.
The normal process that removes cholesterol particles from the blood stream does not work in patients with this disease. It causes cholesterol to build-up in the arteries and leads to hardening of the arteries (atherosclerosis).
The goal of this study is to detect and measure atherosclerosis in these patients before it becomes permanent and potentially life threatening. Patients with this disease can participate in this study. Researchers plan to evaluate patients with homozygous familial hypercholesterolemia using new and standard methods for detecting atherosclerosis.
Researchers plan to use information gathered during this study to develop new, promising treatments such as liver transplantation and gene therapy.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||73 participants|
|Official Title:||Cardiovascular Evaluation of Homozygous Familial Hypercholesterolemia|
|Study Start Date :||May 28, 1985|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001204
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|
|Principal Investigator:||Robert D Shamburek, M.D.||National Heart, Lung, and Blood Institute (NHLBI)|